A detailed history of Aries Wealth Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aries Wealth Management holds 475 shares of VRTX stock, worth $238,663. This represents 0.06% of its overall portfolio holdings.

Number of Shares
475
Previous 475 -0.0%
Holding current value
$238,663
Previous $222,000 0.9%
% of portfolio
0.06%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$392.81 - $485.53 $186,584 - $230,626
475 New
475 $222,000
Q4 2021

Jan 18, 2022

BUY
$177.01 - $223.45 $495,628 - $625,660
2,800 New
2,800 $615,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Aries Wealth Management Portfolio

Follow Aries Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aries Wealth Management with notifications on news.